Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01020019

Combined Pharmacotherapy for Cannabis Dependency (D-LUCS)

A Randomized, Double-Blind, Placebo-Controlled Study of Lofexidine and Dronabinol for the Treatment of Marijuana Dependence

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cannabis Dependence Marijuana Dependence

Interventions Dronabinol Lofexidine Placebo

Updated 8 times since 2017 Last updated: Apr 22, 2019 Started: Jan 31, 2010 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Cannabis Dependence and Marijuana Dependence, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
May 2019 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Dec 2018 — May 2019 [monthly]

Completed PHASE2_PHASE3

▶ Show 3 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States